Publicaciones (102) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Clinical outcomes and antibody transfer in a cohort of infants with in utero or perinatal exposure to SARS-CoV-2 (Coronascope Study)

    European Journal of Pediatrics, Vol. 182, Núm. 10, pp. 4647-4654

  2. Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines

    Journal of Medical Virology, Vol. 95, Núm. 1

  3. Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  4. Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox

    Clinical Infectious Diseases, Vol. 76, Núm. 7, pp. 1311-1314

  5. Rapid screening of SARS-CoV-2 variants, a key tool for pandemic surveillance

    Scientific Reports, Vol. 13, Núm. 1

  6. Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals

    Journal of Medical Virology, Vol. 95, Núm. 11

  7. Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain

    International Journal of Infectious Diseases, Vol. 136, pp. 37-42

  8. The emergence, impact, and evolution of human metapneumovirus variants from 2014 to 2021 in Spain

    Journal of Infection, Vol. 87, Núm. 2, pp. 103-110

  9. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

  10. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain

    The Lancet Infectious Diseases, Vol. 23, Núm. 4, pp. 445-453

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses

    Frontiers in Immunology, Vol. 13

  3. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study

    The Lancet, Vol. 400, Núm. 10353, pp. 661-669

  4. Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication

    Transplant International, Vol. 35

  5. Derivation and external validation of a simple prediction rule for the development of respiratory failure in hospitalized patients with influenza

    Respiratory Research, Vol. 23, Núm. 1

  6. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 546-549

  7. Genetic polymorphisms in TLR3, IL10 and CD209 influence the risk of BK polyomavirus infection after kidney transplantation

    Scientific Reports, Vol. 12, Núm. 1

  8. Influenza A-Associated In-Hospital Mortality in Very Older People: Does Inflammation Also Play a Role?

    Gerontology, Vol. 68, Núm. 7, pp. 780-788

  9. Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19-Convalescent Individuals

    The Journal of infectious diseases, Vol. 225, Núm. 11, pp. 1905-1908

  10. Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events

    Atherosclerosis Plus, Vol. 48, pp. 37-46